Alnylam Gets Milestone From Roche

Cambridge, MA-based Alnylam Pharmaceuticals said Wednesday it has received an undisclosed milestone payment from its partner, Roche, for starting studies that pave the way for clinical trials of a certain drug candidate.
Xconomy